BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats. J Gastroenterol 2017;52:72-80. [DOI: 10.1007/s00535-016-1208-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tachibana T, Nakatani A, Khan S, Makino R, Cline MA. Effect of lithium chloride on food intake, cloacal temperature, voluntary activity, and crop-emptying rate in chicks. Comp Biochem Physiol A Mol Integr Physiol 2022;:111284. [PMID: 35918017 DOI: 10.1016/j.cbpa.2022.111284] [Reference Citation Analysis]
2 van Thiel IAM, Botschuijver S, de Jonge WJ, Seppen J. Painful interactions: Microbial compounds and visceral pain. Biochim Biophys Acta Mol Basis Dis 2020;1866:165534. [PMID: 31634534 DOI: 10.1016/j.bbadis.2019.165534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats. J Gastroenterol Hepatol. 2018;33:232-239. [PMID: 28440889 DOI: 10.1111/jgh.13808] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
4 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. Sci Rep 2019;9:19603. [PMID: 31862976 DOI: 10.1038/s41598-019-56132-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
5 Okumura T, Nozu T, Ishioh M, Igarashi S, Kumei S, Ohhira M. Centrally administered butyrate improves gut barrier function, visceral sensation and septic lethality in rats. J Pharmacol Sci 2021;146:183-91. [PMID: 34116731 DOI: 10.1016/j.jphs.2021.04.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Arie H, Nozu T, Miyagishi S, Ida M, Izumo T, Shibata H. Grape Seed Extract Eliminates Visceral Allodynia and Colonic Hyperpermeability Induced by Repeated Water Avoidance Stress in Rats. Nutrients 2019;11:E2646. [PMID: 31689935 DOI: 10.3390/nu11112646] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102248] [Reference Citation Analysis]
8 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. European Journal of Pharmacology 2019;852:198-206. [DOI: 10.1016/j.ejphar.2019.03.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats. European Journal of Pharmacology 2018;818:228-34. [DOI: 10.1016/j.ejphar.2017.10.056] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
10 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats: Metformin improves visceral pain. Journal of Gastroenterology and Hepatology 2019;34:186-93. [DOI: 10.1111/jgh.14367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
11 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13819. [PMID: 32056324 DOI: 10.1111/nmo.13819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kittana M, Ahmadani A, Al Marzooq F, Attlee A. Dietary Fat Effect on the Gut Microbiome, and Its Role in the Modulation of Gastrointestinal Disorders in Children with Autism Spectrum Disorder. Nutrients 2021;13:3818. [PMID: 34836074 DOI: 10.3390/nu13113818] [Reference Citation Analysis]
13 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome. Eur J Pharmacol 2020;887:173565. [PMID: 32946869 DOI: 10.1016/j.ejphar.2020.173565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome. J Pharmacol Sci 2019;139:46-9. [PMID: 30522964 DOI: 10.1016/j.jphs.2018.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
15 Accarie A, Vanuytsel T. Animal Models for Functional Gastrointestinal Disorders. Front Psychiatry 2020;11:509681. [PMID: 33262709 DOI: 10.3389/fpsyt.2020.509681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1. Journal of Endocrinology 2018;239:241-52. [DOI: 10.1530/joe-18-0441] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
17 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome. Biomed Pharmacother 2021;139:111649. [PMID: 33957565 DOI: 10.1016/j.biopha.2021.111649] [Reference Citation Analysis]
18 Pardo-camacho C, Ganda Mall J, Martínez C, Pigrau M, Expósito E, Albert-bayo M, Melón-ardanaz E, Nieto A, Rodiño-janeiro B, Fortea M, Guagnozzi D, Rodriguez-urrutia A, Torres ID, Santos-briones I, Azpiroz F, Lobo B, Alonso-cotoner C, Santos J, González-castro AM, Vicario M. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations. Cells 2022;11:2046. [DOI: 10.3390/cells11132046] [Reference Citation Analysis]
19 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor: Stress and visceral hypersensitivity. Journal of Gastroenterology and Hepatology 2017;32:1958-65. [DOI: 10.1111/jgh.13787] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
20 Yang M, Hong G, Jin Y, Li Y, Li G, Hou X. Mucosal-Associated Microbiota Other Than Luminal Microbiota Has a Close Relationship With Diarrhea-Predominant Irritable Bowel Syndrome. Front Cell Infect Microbiol 2020;10:515614. [PMID: 33224895 DOI: 10.3389/fcimb.2020.515614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Nozu T, Miyagishi S, Nozu R, Ishioh M, Takakusaki K, Okumura T. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome. J Pharmacol Sci 2021;146:121-4. [PMID: 34030794 DOI: 10.1016/j.jphs.2021.04.001] [Reference Citation Analysis]